Mannkind (MNKD) Work In Process (2014 - 2026)
Mannkind (MNKD) reported Work In Process of $32.4 million for Q1 2026, up 137.52% year-over-year from $13.6 million in Q1 2025, and up 192.15% on a QoQ basis from $11.1 million in Q4 2025.
Mannkind (MNKD) has 13 years of Work In Process data on file, last reported at $32.4 million in Q1 2026.
- Quarterly Work In Process rose 137.52% year-over-year to $32.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.4 million (up 137.52% YoY) and the FY2025 annual result came in at $11.1 million, up 4.0% from the prior year.
- Work In Process rose to $32.4 million in Q1 2026 per MNKD's latest filing, from $11.1 million in the prior quarter.
- Across five years, Work In Process topped out at $32.4 million in Q1 2026 and bottomed at $3.3 million in Q1 2022.
- The 5-year median for Work In Process is $10.7 million (2023), against an average of $11.6 million.
- The widest annual swing landed in 2022, when Work In Process jumped 889.73%; it then declined 26.23% in 2024.
- Tracing MNKD's Work In Process over 5 years: stood at $13.8 million in 2022, then slipped by 1.22% to $13.6 million in 2023, then decreased by 21.87% to $10.7 million in 2024, then grew by 4.0% to $11.1 million in 2025, then jumped by 192.15% to $32.4 million in 2026.
- Per Business Quant, the three latest MNKD Work In Process figures stand at $32.4 million (Q1 2026), $11.1 million (Q4 2025), and $10.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.39 Mn |
| Dec 31, 2025 | 11.09 Mn |
| Sep 30, 2025 | 10.09 Mn |
| Jun 30, 2025 | 12.28 Mn |
| Mar 31, 2025 | 13.64 Mn |
| Dec 31, 2024 | 10.66 Mn |
| Sep 30, 2024 | 9.07 Mn |
| Jun 30, 2024 | 9.78 Mn |
| Mar 31, 2024 | 12.31 Mn |
| Dec 31, 2023 | 13.65 Mn |
| Sep 30, 2023 | 12.30 Mn |
| Jun 30, 2023 | 10.70 Mn |
| Mar 31, 2023 | 8.05 Mn |
| Dec 31, 2022 | 13.82 Mn |
| Sep 30, 2022 | 8.24 Mn |
| Jun 30, 2022 | 6.37 Mn |
| Mar 31, 2022 | 3.28 Mn |
| Dec 31, 2021 | 2.52 Mn |
| Sep 30, 2021 | 1.79 Mn |
| Jun 30, 2021 | 3.10 Mn |
| Mar 31, 2021 | 331,000.00 |
| Dec 31, 2020 | 2.48 Mn |
| Sep 30, 2020 | 1.83 Mn |
| Jun 30, 2020 | 1.68 Mn |
| Mar 31, 2020 | 495,000.00 |
| Dec 31, 2019 | 1.43 Mn |
| Sep 30, 2019 | 1.68 Mn |
| Jun 30, 2019 | 1.33 Mn |
| Mar 31, 2019 | 1.59 Mn |
| Dec 31, 2018 | 1.61 Mn |
| Sep 30, 2018 | 732,000.00 |
| Jun 30, 2018 | 1.50 Mn |
| Mar 31, 2018 | 2.52 Mn |
| Dec 31, 2017 | 1.27 Mn |
| Sep 30, 2017 | 2.33 Mn |
| Jun 30, 2017 | 2.39 Mn |
| Mar 31, 2017 | 3.30 Mn |
| Dec 31, 2016 | 2.12 Mn |
| Sep 30, 2016 | 1.77 Mn |
| Jun 30, 2016 | 1.16 Mn |
| Sep 30, 2015 | 3.94 Mn |
| Jun 30, 2015 | 3.76 Mn |
| Mar 31, 2015 | 5.55 Mn |
| Dec 31, 2014 | 4.72 Mn |